Replies to post #103705 on Biotech Values

[DewDiligence]

ZGEN—Since NVS sold their shares at $9.75, I think any further discussion of "fair value" is moot.

NVO is the one who’s divesting ZGEN. (NVS has enough M&A activity on its plate already without having to worry about ZGEN :- ))